Suchergebnisse - %22COVID19%22

PubPharm (329)

1

Postinfectious conditions challenge disease-specificity of SNOT-22

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2024

von Hildebrandt, M. | Møller, P. | Fjældstad, A. | +1

2

Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity

enthalten in: Bioorganic & medicinal chemistry | 2024

von Carney, D. | Leffler, A. | Bell, J. | +17

3

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

enthalten in: Antiviral research | 2024

von Khatua, K. | Alugubelli, Y. | Yang, K. | +17

4

Sensitive detection of SARS-CoV-2 main protease 3CLpro with an engineered ribonuclease zymogen

enthalten in: Protein science : a publication of the Protein Society | 2024

von Wralstad, E. | Raines, R.

5

Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection

enthalten in: Journal of virology | 2024

von Vanslambrouck, J. | Neil, J. | Rudraraju, R. | +9

6

Manidipine is not a potential inhibitor against SARS-CoV-2 main protease

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, R. | Zhou, J. | Yan, H. | +3

7

In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Gutti, G. | He, Y. | Coldren, W. | +5

8

The Frequency and Clinical Assessment of COVID-19 in Patients With Chronic Rhinosinusitis

enthalten in: Ear, nose, & throat journal | 2024

von Akhlaghi, A. | Darabi, A. | Mahmoodi, M. | +5

9

Chrysin 7-O-β-D-glucuronide, a dual inhibitor of SARS-CoV-2 3CLpro and PLpro, for the prevention and treatment of COVID-19

enthalten in: International journal of antimicrobial agents | 2024

von Yi, Y. | Yu, R. | Xue, H. | +7

10

Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

enthalten in: International journal of molecular sciences | 2024

von De Luca, V. | Angeli, A. | Nocentini, A. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]